Literature DB >> 3868340

The effect of cyclophosphamide and vincristine on intestinal protein loss in rats.

T Beró, T Jávor.   

Abstract

24 and 48 hours after a single intraperitoneal dose of 80 mg/kg cyclophosphamide (I. group) and 0.20 mg/kg vincristine (II. group) the intestinal protein loss has been studied using the 51CrCl3 isotope method. 16 animals were used as control (III. group). In case of both cytostatics, the intestinal protein loss was significantly higher. Histologically the small bowel mucosa, on the first day after injection, showed, in the crypts, necrotic cells and mitoses arrested in metaphase. By the second day, after injection, severe villous atrophy and occasional mucosal erosions were seen. The causes of these changes are discussed together with the question of the disrupted barrier function of the small bowel.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3868340     DOI: 10.1007/978-3-642-69928-3_15

Source DB:  PubMed          Journal:  Arch Toxicol Suppl        ISSN: 0171-9750


  2 in total

1.  Translationally relevant mouse model of early life cancer and chemotherapy exposure results in brain and small intestine cytokine responses: A potential link to cognitive deficits.

Authors:  Jan Pieter Konsman; Collin J Laaker; Kelsey R Lloyd; Adam Hiltz; Brittany L Smith; Marissa A Smail; Teresa M Reyes
Journal:  Brain Behav Immun       Date:  2021-10-14       Impact factor: 7.217

2.  Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat.

Authors:  Gema Vera; Ana E López-Pérez; José A Uranga; Rocío Girón; Ma Isabel Martín-Fontelles; Raquel Abalo
Journal:  Front Pharmacol       Date:  2017-02-06       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.